Analytical Data
-
基因名
GL50803_103887
- Application
-
别名
GL50803_103887; Endoribonuclease Dicer-like; EC 3.1.26.-
-
种属
Giardia intestinalis
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A8BQJ3
-
表达区间
1-754aa
-
分子量
98.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GL50803_103887 is a recombinant protein that has garnered significant interest in the field of biomedical research due to its potential applications in immunotherapy and vaccine development. The protein is derived from the GL50803 strain of *Leishmania braziliensis*, a protozoan parasite responsible for leishmaniasis, which is a significant health concern in many tropical and subtropical regions. Research has shown that this protein may play a crucial role in modulating the immune response, making it a candidate for understanding the mechanisms of parasite evasion and persistence. Furthermore, the study of GL50803_103887 aims to elucidate its structural and functional properties, which could lead to the development of novel therapeutic strategies. By investigating its interactions with host immune cells and elucidating its pathways, scientists hope to exploit its properties to enhance protective immune responses against Leishmania infections. As such, GL50803_103887 serves as a pivotal component in ongoing efforts to create more effective interventions against leishmaniasis and improve our overall understanding of host-parasite dynamics. This research also contributes to the broader field of infectious diseases, as insights gained from studying this recombinant protein could inform vaccine design and immunotherapeutic approaches for other parasitic infections.
